Blue Clay Capital Management’s SteadyMed Ltd STDY Stock Holding History

Blue Clay Capital Management’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-99,810	Closed	-$246K	–	129
2016 Q1	$246K	Buy	99,810 +5,260	+6%	+$13.1K	0.23%	101
2015 Q4	$308K	Buy	94,550 +57,400	+155%	+$173K	0.26%	88
2015 Q3	$132K	Hold	37,150	–	–	0.11%	90
2015 Q2	$198K	Buy	+37,150	New	+$300K	0.11%	79

Other funds holding STDY

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Blue Clay Capital Management's STDY Position: Q2 2016 in Review

Blue Clay Capital Management sold out of SteadyMed Ltd (STDY) in Q2 2016, closing a stake of 99,810 shares — an estimated $246K sold.

Blue Clay Capital Management first reported a position in STDY in Q2 2015 and held it in 4 quarters. The position peaked at $308K in Q4 2015. 15 funds tracked by Wall St. Rank hold STDY as of Q2 2016.

Blue Clay Capital Management reported no remaining SteadyMed Ltd position as of Q2 2016 after selling out during the quarter.
Blue Clay Capital Management sold 99,810 SteadyMed Ltd shares in Q2 2016, an estimated $246K.
Blue Clay Capital Management first reported a position in SteadyMed Ltd in Q2 2015 and held it in 4 quarters.
Blue Clay Capital Management's SteadyMed Ltd position peaked at $308K in Q4 2015.
15 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2016.

Based on Blue Clay Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.